Feu F - Search Results

1

[Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].

François E, García-Pagán JC, Bru C, Feu F, Gilabert R, Escorsell A, Bosch J, Rodés J. François E, et al. Among authors: feu f. Gastroenterol Hepatol. 1997 Jan;20(1):1-4. Gastroenterol Hepatol. 1997. PMID: 9072189 Spanish.

2

Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.

Bosch J, Pizcueta MP, Fernández M, Feu F, Cirera I, Luca A, García-Pagán JC. Bosch J, et al. Among authors: feu f. Baillieres Clin Gastroenterol. 1992 Sep;6(3):425-36. doi: 10.1016/0950-3528(92)90030-i. Baillieres Clin Gastroenterol. 1992. PMID: 1421593 Review.

3

Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow.

Lacy AM, Navasa M, Gilabert R, Brú C, García-Pagán JC, García-Valdecasas JC, Grande L, Feu F, Fuster J, Terés J, et al. Lacy AM, et al. Among authors: feu f. Hepatology. 1992 Apr;15(4):616-22. doi: 10.1002/hep.1840150411. Hepatology. 1992. PMID: 1551639

4

Pathophysiology of portal hypertension.

Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Bosch J, et al. Among authors: feu f. Gastroenterol Clin North Am. 1992 Mar;21(1):1-14. Gastroenterol Clin North Am. 1992. PMID: 1568769 Review.

5

Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.

Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta MP, Bosch J, Rodés J. Ruiz del Arbol L, et al. Among authors: feu f. J Hepatol. 1991 Sep;13(2):179-86. doi: 10.1016/0168-8278(91)90812-p. J Hepatol. 1991. PMID: 1744422 Clinical Trial.

6

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.

García-Pagán JC, Feu F, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: feu f. Ann Intern Med. 1991 May 15;114(10):869-73. doi: 10.7326/0003-4819-114-10-869. Ann Intern Med. 1991. PMID: 2014947 Clinical Trial.

7

Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension.

Feu F, Bordas JM, Garcia-Pagán JC, Bosch J, Rodés J. Feu F, et al. Hepatology. 1991 May;13(5):917-22. Hepatology. 1991. PMID: 2029996 Clinical Trial.

8

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: feu f. J Hepatol. 1990 Sep;11(2):189-95. doi: 10.1016/0168-8278(90)90112-5. J Hepatol. 1990. PMID: 2123914 Clinical Trial.

9

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.

Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, Rodés J. Feu F, et al. Lancet. 1995 Oct 21;346(8982):1056-9. doi: 10.1016/s0140-6736(95)91740-3. Lancet. 1995. PMID: 7564785 Clinical Trial.

10

Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.

Luca A, García-Pagán JC, Feu F, Lopez-Talavera JC, Fernández M, Bru C, Bosch J, Rodés J. Luca A, et al. Among authors: feu f. Hepatology. 1995 Jan;21(1):83-8. Hepatology. 1995. PMID: 7806173 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters